Chardan Capital reiterated coverage on PDS Biotechnology with a new price target

5/20/21 8:28:13 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Chardan Capital reiterated coverage of PDS Biotechnology with a rating of Buy and set a new price target of $11.00 from $10.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PDSB

Date	Price Target	Rating	Analyst
11/1/2022	$10.00	Buy	B. Riley Securities
8/12/2021	$20.00 → $15.00	Buy	HC Wainwright & Co.
6/28/2021	$25.00	Overweight	Cantor Fitzgerald